ProPhase Labs Inc has a consensus price target of $5.5, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on February 21, 2024, November 10, 2023, and August 14, 2023. With an average price target of $12 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 83.49% upside for ProPhase Labs Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/21/2024 | PRPH | Buy Now | ProPhase Labs | $6.54 | 68.2% | HC Wainwright & Co. | Yi Chen | → $11 | Reiterates | Buy → Buy | Get Alert |
11/10/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 68.2% | HC Wainwright & Co. | Yi Chen | $14 → $11 | Maintains | Buy | Get Alert |
08/14/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 114.07% | HC Wainwright & Co. | Yi Chen | → $14 | Reiterates | Buy → Buy | Get Alert |
06/02/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 114.07% | HC Wainwright & Co. | Yi Chen | → $14 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 114.07% | HC Wainwright & Co. | Yi Chen | $15 → $14 | Maintains | Buy | Get Alert |
03/08/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | → $15 | Reiterates | → Buy | Get Alert |
02/23/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | → $15 | Reiterates | → Buy | Get Alert |
02/16/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | → $15 | Reiterates | → Buy | Get Alert |
02/07/2023 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | → $15 | Reiterates | → Buy | Get Alert |
11/11/2022 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | $14 → $15 | Maintains | Buy | Get Alert |
05/17/2022 | PRPH | Buy Now | ProPhase Labs | $6.54 | 114.07% | HC Wainwright & Co. | Yi Chen | $16 → $14 | Maintains | Buy | Get Alert |
03/31/2022 | PRPH | Buy Now | ProPhase Labs | $6.54 | 144.65% | HC Wainwright & Co. | Yi Chen | $15 → $16 | Maintains | Buy | Get Alert |
01/14/2022 | PRPH | Buy Now | ProPhase Labs | $6.54 | 129.36% | HC Wainwright & Co. | Yi Chen | $12 → $15 | Maintains | Buy | Get Alert |
12/20/2021 | PRPH | Buy Now | ProPhase Labs | $6.54 | 83.49% | HC Wainwright & Co. | Yi Chen | — | Initiates | → Buy | Get Alert |
10/13/2021 | PRPH | Buy Now | ProPhase Labs | $6.54 | — | Dawson James | Jason Kolbert | — | Downgrade | Buy → Neutral | Get Alert |
The latest price target for ProPhase Labs (NASDAQ: PRPH) was reported by HC Wainwright & Co. on February 21, 2024. The analyst firm set a price target for $11.00 expecting PRPH to rise to within 12 months (a possible 68.20% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for ProPhase Labs (NASDAQ: PRPH) was provided by HC Wainwright & Co., and ProPhase Labs reiterated their buy rating.
There is no last upgrade for ProPhase Labs.
The last downgrade for ProPhase Labs Inc happened on October 13, 2021 when Dawson James changed their price target from N/A to N/A for ProPhase Labs Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProPhase Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProPhase Labs was filed on February 21, 2024 so you should expect the next rating to be made available sometime around February 21, 2025.
While ratings are subjective and will change, the latest ProPhase Labs (PRPH) rating was a reiterated with a price target of $0.00 to $11.00. The current price ProPhase Labs (PRPH) is trading at is $6.54, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.